Chemoinformaics analysis of neochebulagic-acid
| Molecular Weight | 274.316 | nRot | 5 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 12 |
| Exact Molecular Weight | 274.121 | nRing | 2 |
| Solubility: LogS | -3.435 | nHRing | 0 |
| Solubility: LogP | 3.06 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 41.9303 |
| nHD | 2 | BPOL | 21.5297 |
| QED | 0.88 |
| Synth | 1.992 |
| Natural Product Likeliness | 0.783 |
| NR-PPAR-gamma | 0.055 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.216 |
| Pgp-sub | 0.031 |
| HIA | 0.006 |
| CACO-2 | -4.888 |
| MDCK | 0.0000154 |
| BBB | 0.047 |
| PPB | 0.972262 |
| VDSS | 1.258 |
| FU | 0.0228631 |
| CYP1A2-inh | 0.977 |
| CYP1A2-sub | 0.951 |
| CYP2c19-inh | 0.938 |
| CYP2c19-sub | 0.309 |
| CYP2c9-inh | 0.753 |
| CYP2c9-sub | 0.96 |
| CYP2d6-inh | 0.944 |
| CYP2d6-sub | 0.929 |
| CYP3a4-inh | 0.874 |
| CYP3a4-sub | 0.361 |
| CL | 12.812 |
| T12 | 0.867 |
| hERG | 0.175 |
| Ames | 0.036 |
| ROA | 0.029 |
| SkinSen | 0.949 |
| Carcinogencity | 0.036 |
| EI | 0.957 |
| Respiratory | 0.393 |
| NR-Aromatase | 0.063 |
| Antiviral | No |
| Prediction | 0.700821 |